<?xml version="1.0" encoding="UTF-8"?>
<p>EuPFI is currently a consortium of 10 pharmaceutical companies, 5 universities, 1 hospital and, exclusively, the European Medicines Agency (EMA) as an observer. The goals and objectives of this consortium are summarized in [
 <xref rid="B19-pharmaceutics-13-00387" ref-type="bibr">19</xref>]:
 <list list-type="order">
  <list-item>
   <p>Identify the problems and challenges associated with the development of paediatric formulation and consider ways to obtain better medicines and dosage forms clinically relevant to children.</p>
  </list-item>
  <list-item>
   <p>Promote early pharmaceutical consideration for the development of paediatric medicines. </p>
  </list-item>
  <list-item>
   <p>Identify potential information and knowledge gaps in the development of paediatric formulations.</p>
  </list-item>
  <list-item>
   <p>Improve the availability of information from paediatric formulations.</p>
  </list-item>
 </list>
</p>
